Author: Kevin Grogan

GSK pays $105 million to settle alleged illegal marketing

GlaxoSmithKline has been sanctioned concerning its future marketing initiatives after agreeing to a $105 million settlement in the USA regarding alleged unlawful promotion of chronic obstructive pulmonary disease and asthma blockbuster Advair and the antidepressants Paxil and Wellbutrin.

Read More